Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZATMATM0,00
KBATMATM0,00
PKN144,32144,91,20
Msft-1,18
Nokia-1,68
IBM-1,41
Mercedes-Benz Group AG48,3550,75
PFE-1,61
09.06.2026 9:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 08.06.2026
CONMED (NY Consolidated)
Závěr k 8.6.2026 Změna (%) Změna (USD) Objem obchodů (USD)
34,49 -1,91 -0,67 9 938 538
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiConmed Corp
TickerCNMD
Kmenové akcie:Ordinary Shares
RICCNMD.K
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 3 900
Akcie v oběhu k 27.04.2026 30 109 194
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice11311 Concept Boulevard
MěstoLARGO
PSČ33773
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon13 026 587 581
Fax13026555049

Business Summary: CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Conmed Corp revenues decreased 1% to $317M. Net income increased from $6M to $13.8M. Revenues reflect Development, manufacturing and sale on a global basis of sur segment decrease of 7% to $169.4M, United States segment decrease of 6% to $173.1M, Asia Pacific segment decrease of 4% to $42M. Net income reflects Selling and administrative expense decrease of 2% to $136.9M (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSOther Measuring and Controlling Device Manufacturing
NAICSIrradiation Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
SICElectromedical Equipment
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICMeasuring/controlling Devices Nec
SICX-Ray Apparatus And Tubes



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorPatrick Beyer6001.01.2025
Interim Principal Chief Financial Officer, Vice President, ControllerAndrew Moller5115.03.202627.02.2025
Executive Vice President, General Counsel and Corporate SecretaryHollie Foust51
Executive Vice President, Human ResourcesJohn Ferrell58
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial OperationsBrent Lalomia5101.04.2022
Executive Vice President - Strategy and Corporate DevelopmentPeter Shagory5711.05.201511.05.2015
Interim Corporate Controller, Interim Principal Accounting OfficerKimberly Lockwood4901.06.202630.09.2024
Chief Information OfficerRichard Glaze60
Vice President, General Manager, U.S. Advanced SurgicalMatthew Schabacker4501.01.2025
Treasurer and Vice President - TaxJohonna Pelletier5301.04.201501.04.2015